News

TUESDAY, Feb. 3, 2026 -- In guidelines issued by the American Society of Hematology and published online Jan. 27 in Blood Advances, recommendations are presented…

To everyone touched by transthyretin (ATTR) amyloidosis; through diagnosis, genetics, or love, come sit with me for a moment.My father's ATTR diagnosisSo, there we…

Raising Youth Voices is a global collaboration between the National Organization for Rare Disorders (NORD), EURORDIS-Rare Diseases Europe, and Rare Diseases…

Isabelle LousadaFounder & CEOAmyloidosis Research Consortium Transthyretin amyloid cardiomyopathy (ATTR-CM), including both wild-type (ATTRwt) and…

Key TakeawaysAmyloidosis is a rare disease where abnormal proteins build up in the body, and when it affects the eye, it can cause symptoms ranging from mild…

Key TakeawaysHereditary transthyretin amyloidosis is a rare life-threatening disease caused by misfolded proteins that clump together and build up in organs…

Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs.  Approximately 3,260…

This thesis of Hendrea Tingen investigates how nuclear imaging can improve the diagnosis, monitoring of disease progression, and evaluation of treatment response in…

The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a Phase 3 clinical trial testing the investigational gene-editing therapy, nexiguran…

Cardiac amyloidosis is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins, most commonly immunoglobulin light chains (AL) or…